Debt-to-equity in % of Context Therapeutics Inc. from Q2 2022 to Q3 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Context Therapeutics Inc. quarterly Debt-to-equity history and change rate from Q2 2022 to Q3 2025.
Context Therapeutics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 4.5%, a 14% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Context Therapeutics Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	4.5%	-0.76%	-14%	30 Sep 2025
Q2 2025	3.4%	-5.9%	-64%	30 Jun 2025
Q1 2025	2.4%	-22%	-90%	31 Mar 2025
Q4 2024	3.3%	-16%	-83%	31 Dec 2024
Q3 2024	5.3%	-8.7%	-62%	30 Sep 2024
Q2 2024	9.3%	-2%	-18%	30 Jun 2024
Q1 2024	24%	+15%	+156%	31 Mar 2024
Q4 2023	19%	+12%	+155%	31 Dec 2023
Q3 2023	14%	+7.2%	+107%	30 Sep 2023
Q2 2023	11%	+0.5%	+4.6%	30 Jun 2023
Q1 2023	9.4%			31 Mar 2023
Q4 2022	7.4%			31 Dec 2022
Q3 2022	6.8%			30 Sep 2022
Q2 2022	11%			30 Jun 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.